Friday, July 31, 2026

Trump’s 15%→25% Tariff Threat Still Looms: Seoul’s Top Diplomat Says the U.S. Wants Faster Legislative Action, Not More Explanations

South Korea's Foreign Minister Cho Hyun reports U.S. concerns over trade commitments, amid rising tariff threats from the Trump administration.

North Korea’s Response to the U.S. Secretary of State Visiting South Korea: Fire Ballistic Missiles Into the Sea

North Korea fired several ballistic missiles into...

New Ammonia Sensor Technology: Low-Temperature, Flexible, and Cost-Effective

KIMS developed the first flexible CuBr-based ammonia sensor, enhancing sensitivity and reducing costs for various applications.

Tag: CDMO

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Samsung Biologics: How a 56 Billion USD CDMO Leader is Shaping the Future of Biopharmaceuticals

Samsung Biologics is evolving as a leading CDMO, targeting a production capacity of 1.32M liters by 2030 after its spin-off from Bioepis.

ST Pharm’s Record Growth: How RNA-Based Therapies Are Transforming the CDMO Market in 2026

ST Pharm reports record growth in oligonucleotide CDMO, driven by rising demand for RNA-based treatments for chronic diseases.

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

GAME OVER: Samsung Biologics Declares War With ‘ExellenS’—A Standard That Kills All Biotech Competition

Samsung Biologics launches ExellenS in Europe, enhancing biopharmaceutical production with standardized quality and efficiency.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.